JACKSONVILLE, Fla.--(BUSINESS WIRE)--PSS World Medical, Inc. (NASDAQ GS:PSSI) announced today that it has entered into a unique agreement with Novartis Vaccines and Diagnostics, Inc. (“Novartis”) to act, under a fee-for-service arrangement, as a sales agent and to provide logistical and related services to its customers for the sale of Novartis’ FLUVIRIN® influenza virus vaccine.
